Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing
Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)
Who this might be right for
Alzheimer's Disease
Targacept Inc. 386